- Research works
- 3 fractional, all time
- Citations
- 18 5.9 per fractional work
- Top-10% rate
- 32.5% record average 16.5%
- Open access
- 92% world 28%
Not ranked overall: Lipigon Pharmaceuticals (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Lipigon Pharmaceuticals (Sweden) publish most on?
By volume in 2022–2025: Lipid metabolism and disorders, Cancer, Hypoxia, and Metabolism, Cancer, Lipids, and Metabolism and Cancer-related molecular mechanisms research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lipid metabolism and disorders Cardiology and Cardiovascular Medicine 1 works
- 2 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
- 3 Cancer, Lipids, and Metabolism Cancer Research 0 works
- 4 Cancer-related molecular mechanisms research Cancer Research 0 works
- 5 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
- 6 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
- 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
- 8 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 9 Kruppel-like factors research Molecular Biology 0 works
- 10 Genetic Associations and Epidemiology Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Umeå
- Umeå University
- University Hospital of Umeå
- Arctic Research Centre
- Umeå Plant Science Centre
- Centre for Biomedical Engineering and Physics
- Västerbotten County
- Boréa (Sweden)
- LunaLEC (Sweden)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.